{"id":"adverse-reactions-of-botox-intramuscularly","safety":{"commonSideEffects":[{"rate":"15%","effect":"dysphagia"},{"rate":"10%","effect":"dry mouth"},{"rate":"8%","effect":"headache"},{"rate":"5%","effect":"eye swelling"},{"rate":"5%","effect":"muscle weakness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Botulinum toxin works by cleaving SNAP-25, a protein essential for the release of acetylcholine from the presynaptic neuron, thereby preventing muscle contraction.","oneSentence":"Botulinum toxin inhibits acetylcholine release at neuromuscular junctions","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T05:50:51.530Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"blepharospasm"},{"name":"strabismus"},{"name":"cervical dystonia"},{"name":"hemicrania continua"}]},"trialDetails":[{"nctId":"NCT02074150","phase":"PHASE1, PHASE2","title":"ASIS for Botox in Upper Limb Spasticity","status":"UNKNOWN","sponsor":"li nguyen","startDate":"2016-01","conditions":"Upper Limb Spasticity Unilaterally in Adults With History of Stroke, Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors.","enrollment":60},{"nctId":"NCT02074163","phase":"PHASE1, PHASE2","title":"ASIS for Botox in Chronic Migraine","status":"UNKNOWN","sponsor":"ASIS Corporation","startDate":"2016-01","conditions":"Chronic Migraine More than15 Days Per Month, and Lasting 4 Hours a Day or Longer.","enrollment":60},{"nctId":"NCT02074293","phase":"PHASE1, PHASE2","title":"ASIS for Botox in Cervical Dystonia","status":"UNKNOWN","sponsor":"li nguyen","startDate":"2016-01","conditions":"Cervical Dystonia Adults ,, Abnormal Head Position and Neck Pain for These 7 Muscle Groups: Splenius,Scalene,Sterno-cleido-mastoid,Levator Scapulae,Semispinalis,Trapezius,and Longissimus.","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Botox (onabotulinumtoxinA)"],"phase":"phase_1","status":"active","brandName":"Adverse Reactions of Botox intramuscularly","genericName":"Adverse Reactions of Botox intramuscularly","companyName":"ASIS Corporation","companyId":"asis-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Botulinum toxin inhibits acetylcholine release at neuromuscular junctions Used for blepharospasm, strabismus, cervical dystonia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}